Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Bioorg Med Chem. 2019 Jun 4;27(15):3254–3278. doi: 10.1016/j.bmc.2019.06.003

Scheme 5.

Scheme 5.

Reagents and conditions: a) i) ethyl chloroformate, Et3N, THF; ii) TMSCH2N2, ACN, 24 hr., +4 °C (54%); b) silver benzoate, Et3N, anhydrous methanol (55%); c) LiBH4, THF, ethanol (78%); d) phthalimide, DIAD, PPh3, THF (53%); e) hydrazine, methanol (90%); f) 2-phenethyl-4-phenylbutanoic acid, EDC, HOBT, 2,6-lutidine, DMF(75%); g) 20% Pd(OH)2/C, H2, ethanol (100%).